Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Insys Therapeutics Inc (INSY)

Insys Therapeutics Inc (INSY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 21,707
  • Shares Outstanding, K 74,569
  • Annual Sales, $ 82,080 K
  • Annual Income, $ -124,510 K
  • 60-Month Beta 3.21
  • Price/Sales 0.27
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.74
  • Most Recent Earnings -0.55 on 05/13/19
  • Next Earnings Date 05/14/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.37
  • Growth Rate Est. (year over year) +270,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.14 +105.00%
on 06/11/19
1.90 -84.68%
on 06/06/19
-0.77 (-72.54%)
since 05/17/19
3-Month
0.14 +105.00%
on 06/11/19
4.97 -94.14%
on 04/09/19
-4.10 (-93.37%)
since 03/18/19
52-Week
0.14 +105.00%
on 06/11/19
11.65 -97.50%
on 08/30/18
-7.47 (-96.25%)
since 06/18/18

Most Recent Stories

More News
Medical Cannabis Market Size, Top Countries Data ,Share 2020 Regional Trend, Future Growth, Leading Players Updates, Industry Demand, Current and Future Plans by Forecast to 2024

APHA : 4.89 (-0.41%)
ACB.TO : 14.23 (+4.25%)
CBDS : 0.5400 (-1.80%)
CMMDF : 20.9880 (-7.13%)
INSY : 0.29 (unch)
MJNA : 0.0144 (+2.13%)
MEDFF : 18.8100 (-0.37%)
Medical Cannabis Market Share, Trend, Opportunity, Affect On Demand By COVID-19 Pandemic And Forecast 2020-2024

APHA : 4.89 (-0.41%)
ACB.TO : 14.23 (+4.25%)
CBDS : 0.5400 (-1.80%)
CMMDF : 20.9880 (-7.13%)
INSY : 0.29 (unch)
MJNA : 0.0144 (+2.13%)
MEDFF : 18.8100 (-0.37%)
Medical Cannabis Market Size Detailed Analysis of Current Industry Figures with Forecasts Growth By 2024

Selbyville, Delaware According to Market Study Report LLC adds new research on Medical Cannabis market, which is a detailed analysis of this business space inclusive of the trends, competitive landscape,...

APHA : 4.89 (-0.41%)
ACB.TO : 14.23 (+4.25%)
CBDS : 0.5400 (-1.80%)
CMMDF : 20.9880 (-7.13%)
INSY : 0.29 (unch)
MJNA : 0.0144 (+2.13%)
MEDFF : 18.8100 (-0.37%)
Corona Impact: Is Medical Marijuana Market will Propel at a Defining Pace 2020

APHA : 4.89 (-0.41%)
ACB.TO : 14.23 (+4.25%)
CBDS : 0.5400 (-1.80%)
INSY : 0.29 (unch)
Medical Cannabis Market Report 2020: Industry Trends, Share, Size, Demand, COVID-19 Impact Analysis, And Future Scope

Global Medical Cannabis Market Report by Derivative (Cannabidiol (CBD), Tetrahydrocannabinol (THC), Others), Species (Indica, Sativa, Hybrid), Application (Cancer, Arthritis, Migraine, Epilepsy, Others),...

APHA : 4.89 (-0.41%)
ACB.TO : 14.23 (+4.25%)
CBDS : 0.5400 (-1.80%)
INSY : 0.29 (unch)
MEDFF : 18.8100 (-0.37%)
CNAB : 0.0165 (-65.63%)
GWPH : 135.37 (+1.88%)
ACB : 10.73 (+2.98%)
Medical Marijuana Market 2020 Research Report With COVID-19 Update, Growth Strategy and Industry Development to 2026

The report provides rational insights along with historical and forecast data to aid in better understanding of the Global Medical Marijuana Market. The report provides a comprehensive analysis of key...

ACB.TO : 14.23 (+4.25%)
CMMDF : 20.9880 (-7.13%)
INSY : 0.29 (unch)
MEDFF : 18.8100 (-0.37%)
Medical Cannabis Market Rising Trends, Technology and Business Outlook 2020 to 2024

APHA : 4.89 (-0.41%)
ACB.TO : 14.23 (+4.25%)
CBDS : 0.5400 (-1.80%)
CMMDF : 20.9880 (-7.13%)
INSY : 0.29 (unch)
MJNA : 0.0144 (+2.13%)
MEDFF : 18.8100 (-0.37%)
Recent Analysis on Medicinal Cannabis Market (impact of COVID-19) Growth with Top Companies details like: BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation

APHA : 4.89 (-0.41%)
ACB.TO : 14.23 (+4.25%)
GWPH : 135.37 (+1.88%)
INSY : 0.29 (unch)
HEMP : 0.0050 (unch)
Medical Cannabis Market | Global Industry Analysis, Segments, Top Key Players, Drivers and Trends to 2026

APHA : 4.89 (-0.41%)
ACB.TO : 14.23 (+4.25%)
INSY : 0.29 (unch)
MJNA : 0.0144 (+2.13%)
Industry Report: Medical Cannabis Market Size to grow at 16.82% CAGR by 2023

Selbyville, Delaware According to Market Study Report, Medical Cannabis Market provides a comprehensive analysis of the Medical Cannabis market segments, including their dynamics, size, growth, competitive...

APHA : 4.89 (-0.41%)
ACB.TO : 14.23 (+4.25%)
CBDS : 0.5400 (-1.80%)
CMMDF : 20.9880 (-7.13%)
INSY : 0.29 (unch)
MJNA : 0.0144 (+2.13%)
MEDFF : 18.8100 (-0.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade INSY with:

Business Summary

Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and...

See More

Key Turning Points

2nd Resistance Point 0.44
1st Resistance Point 0.36
Last Price 0.29
1st Support Level 0.24
2nd Support Level 0.18

See More

52-Week High 11.65
Fibonacci 61.8% 7.25
Fibonacci 50% 5.90
Fibonacci 38.2% 4.54
Last Price 0.29
52-Week Low 0.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar